Clinical Trial

Patient's Whole Process Follow-up Management(HOPE-1)

Study acronym: HOPE-1
Recruiting
View on ClinicalTrials.gov →
Summary
Our project is going to explore whether management and follow-up of locally advanced/metastatic patients using the patient process management platform can prolong patient survival and improve patient quality of life.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-04-15; most recent amendment 2022-09-05.
Status change: Not Yet Recruiting → Recruiting 2022-09-05
Trial Details
NCT Number NCT05339568
Lead Sponsor Qianfoshan Hospital
Conditions Locally Advanced Non-Small Cell Lung Cancer, Metastatic NSCLC
Enrollment 1,268 participants
Start Date 2022-05-22
Primary Completion 2030-04-21 (estimated)
Study Completion 2030-08-20 (estimated)
Updated on ClinicalTrials.gov 2022-09-08